Gilead Sciences Inc Completes Waiting Period for Tender Offer for CymaBay Therapeutics Inc
Gilead Sciences, Inc. has successfully completed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its cash ...
Tag: GILD
FDA Issues Black Box Warning for CART Therapies Due to Risk of Secondary TCell Cancers
On January 24, 2024, the U.S. Food and Drug Administration (FDA) made a significant announcement regarding chimeric antigen receptor T-cell ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
